AstraZeneca, Janssen, Novavax Likely To Be Next ‘Warp Speed’ Vaccines In Phase III

While AstraZeneca’s adenovirus candidate is expected to use Operation Warp Speed’s platform, its start date remains cloaked; the Janssen and Novavax candidates are expected to enter Phase III in September and October, respectively.

COVID-19 Vaccine. Corona Virus SARS-CoV-2, 2019 nCoV virus destruction. A vaccine against coronavirus disease 2019. Breakthrough in the Creating of a COVID-19 Vaccine.

The announcement of a deal between GlaxoSmithKline plc, Sanofi Pasteur and the US government for development and production of the companies’ coronavirus vaccine candidate may eventually offer a resolution to the pandemic, but more immediately it appears to offer an answer to the question of which sponsors would win the coveted “three-to-five” clinical trial spots in Operation Warp Speed.

Ever since the administration’s effort to accelerate the availability of a coronavirus vaccine was announced in May, the collaboration between...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Vaccines

More from Pink Sheet